Is Acomplia an FDA Reject?
Popular weight loss drug Acomplia claimed to be the miracle solution to America’s obesity problem. Unfortunately, recent events have discredited the diet pill’s legitimacy and effectiveness. A US Food and Drug Administration (FDA) committee unanimously voted against the pill’s prescription to obese patients.
The “no” vote came from reports saying that the drug causes suicidal thoughts and behavior. An FDA medical officer reported of more patients experiencing anxiety and depression after taking the pill. Dr. Jules Hirsch of Rockfeller University said that more time is needed to study the drug before recommending it for mass use. Individuals diagnosed with depression or any mood disorders should not take Acomplia. Obese individuals who need medication must see their doctor for an accurate diet pill prescription.
How does Acomplia work?
Acomplia is an appetite suppressant diet pill. It works by blocking the CB1 cannabinoid receptor blockers in the brain. These receptors produce the body’s cravings for food, alcohol, cigarettes, and drugs. Because the pill inhibits these blockers, Acomplia consumers tend to eat less and reduce weight within a short period. Healthcare company Sanofi-Aventis is responsible for developing this drug.
Despite its weight loss advantages, the drug’s receptor inhibiting action also leads to psychiatric problems such as anxiety and depression. This comes as no surprise since the drug attacks specific parts of the brain that are responsible for one’s mood and disposition.
Acomplia’s use has been approved in more than 35 countries but Americans are at the greatest risk in using this drug. They are more likely to take Acomplia since many American teenagers and adults suffer from obesity. Americans need to precaution themselves if they are considering Acomplia as their diet medicine.
Advantages of using Acomplia
According to four clinical trials done by Sanofi-Aventis, the drug can reduce the risk of cardiovascular problems and diabetes. Obese patients, whose families have a history of heart problems and diabetes, will benefit the most from these effects. Smokers having a hard time quitting can take Acomplia to reduce their cigarette cravings. The drug can also be taken by alcoholics or smokers fighting their addiction.
To take or not to take?
Acomplia is not a practical choice for individuals with mood disorders. As much as possible, obese patients who have been diagnosed with depression or anxiety disorders should take other diet pills. Those without any psychiatric problems must first refer to Acomplia reviews, which are written by actual customers who have used the product. Unlike product promotions, Acomplia Diet Product reviews provide complete facts and do not hide the dangerous side effects.
Those who prefer to take other diet products can read other weight loss reviews. There are many other anti-obesity products available for patients suffering from psychiatric disorders. Overweight individuals should not resort to diet pills like Acomplia. Most doctors recommend regular exercise and a balanced diet as the healthiest ways to reduce weight. Obese patients who are required diet pills usually partner treatment with exercise and healthy meals. Taking the healthy route will ensure long-term wellness and reduction of fat-related risks.
Like any other drug, Acomplia underwent the New Drug Application (NDA) required by the US Food and Drug Administration. The drug was issued an approval letter in February 2006 but was not permitted to enter the US market. The next year, the FDA’s Endocrine and Metabolic Drug Advisory Committee stated that Sanofi-Aventis was unable to prove Acomplia’s safety as anti-obesity treatment. The European Medicines Agency advised doctors to not prescribe the drug in 2008 for its psychiatric side effects. Obese patients should take note of these events if they decide to buy Acomplia online.
